Optinose to Present at the Needham Virtual Healthcare Conference

YARDLEY, Pa., April 12, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Needham Virtual Healthcare Conference on April 15, 2021, at 11:45 a.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About OptinoseOptinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor ContactJonathan Neely[email protected]267.521.0531

You May Also Be Interested In

• Prospect Floating Rate and Alternative Income Fund Announces a 14.96% Annualized Total Cash Common Shareholder Distribution Rate on Net Asset Value for June 2026
• TECfusions Recognized as Official Sponsor and Participating Partner of Bo Nickal and Historic UFC Freedom 250 Event at the White House
• Compass Working Capital Celebrates Passage of Pilot Program to Strengthen Asset-Building Initiative in Bipartisan Housing Bill